Interaction of cyclosporin A with antilymphocyte serum and with enhancing serum for the suppression of renal allograft rejection in the rat.

@article{Homan1980InteractionOC,
  title={Interaction of cyclosporin A with antilymphocyte serum and with enhancing serum for the suppression of renal allograft rejection in the rat.},
  author={William P. Homan and John Fabre and Peter R. Millard and Peter J. Morris},
  journal={Transplantation},
  year={1980},
  volume={29 3},
  pages={219-22}
}
The interactions between antilymphocyte serum (ALS) and cyclosporin A and between enhancing serum cyclosporin A were investigated in a DA to Lewis rat renal allograft model. Subtherapeutic doses of cyclosporin A (2 mg/kg/day), when combined with enhancing serum, produced no consistently beneficial effect in animal survival. A short course of cyclosporin A… CONTINUE READING